DWT
GMAB icon

Dorsey & Whitney Trust’s Genmab GMAB Stock Holding History

Dorsey & Whitney Trust’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$244K Buy
8,868
+230
+3% +$6.11K 0.01% 655
2026
Q1 		$232K Buy
8,638
+552
+7% +$16.5K 0.01% 642
2025
Q4 		$249K Buy
8,086
+5
+0.1% +$156 0.01% 614
2025
Q3 		$248K Buy
+8,081
New +$197K 0.01% 595
2024
Q1 		– Sell
-6,576
Closed -$209K – 635
2023
Q4 		$209K Sell
6,576
-1,541
-19% -$48.4K 0.02% 568
2023
Q3 		$286K Buy
+8,117
New +$309K 0.02% 439

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Dorsey & Whitney Trust's GMAB Position: Q2 2026 in Review

Dorsey & Whitney Trust increased its Genmab (GMAB) stake by 2.7% in Q2 2026, buying an estimated $6.11K and bringing the position to 8,868 shares worth $244K. The position accounts for 0.01% of the portfolio, ranked #655.

Dorsey & Whitney Trust first reported a position in GMAB in Q3 2023 and has held it in 6 quarters since. The position peaked at $286K in Q3 2023. 291 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Dorsey & Whitney Trust held 8,868 shares of Genmab worth $244K as of Q2 2026.
  • Dorsey & Whitney Trust bought 230 Genmab shares in Q2 2026, an estimated $6.11K.
  • Genmab made up 0.01% of Dorsey & Whitney Trust's portfolio in Q2 2026, its #655 holding.
  • Dorsey & Whitney Trust first reported a position in Genmab in Q3 2023 and has held it in 6 quarters since.
  • Dorsey & Whitney Trust's Genmab position peaked at $286K in Q3 2023.
  • 291 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Dorsey & Whitney Trust's 13F filing for Q2 2026, filed 14 Aug 2026.